Treatment of Hyperhidrosis With Oxybutynin
Information source: University Hospital, Brest
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Hyperhidrosis
Intervention: Oxybutynin (Drug); Placebo (Drug)
Phase: Phase 3
Status: Completed
Sponsored by: University Hospital, Brest Official(s) and/or principal investigator(s): Martine SCHOLLHAMMER, MD, Principal Investigator, Affiliation: ADBO
Summary
Evaluation of the effectiveness of oxybutynin in hyperhidrosis
Clinical Details
Official title: Treatment of Hyperhidrosis With Oxybutynin: a Randomized Controlled Double Blind Against Placebo
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Primary outcome: Evaluation of the effectiveness of oxybutynin in hyperhidrosis
Secondary outcome: Safety evaluation of treatment in this indication
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Age greater than 18 years
- Patient affiliated to social security or beneficiary of such a regime
- Patient able to consent
- Patient with hyperhidrosis, generalized or localized (palmar, plantar, axillary) and
whose score HDSS (Hyperidrosis Disease Severity Scale) is greater than two.
Exclusion Criteria:
- Age less than 18 years
- Patient who can't be followed
- Patient participating in another clinical trial
- Pregnant
- Woman breastfeeding
- Hypersensitivity to oxybutynin or any of the excipients
- Risk of urinary retention related disorders uretroprostatiques
- Intestinal obstruction
- Toxic megacolon
- Intestinal atony
- Severe Ulcerative Colitis
- Myasthenia
- Closure glaucoma the anterior chamber angle or slightly deep
Locations and Contacts
Hospital, Brest, Brest 29609, France
CHG Landerneau, Landerneau 29800, France
CHG de Morlaix, Morlaix 29600, France
Dermatologist'S Office, Quimper 29000, France
Additional Information
Starting date: June 2013
Last updated: July 7, 2014
|